NDC 42292-017-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-017
- Requested NDC
- 42292-017-01
- Package NDCs from labels
- 42292-017-01, 42292-017-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Mylan Institutional Inc. | Mylan Institutional Inc. | 2025-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42292-017-01 | Spironolactone and Hydrochlorothiazide | 1 in 1 BLISTER PACK | TABLET | 1 | 9 | |
| 42292-017-20 | Spironolactone and Hydrochlorothiazide | 100 in 1 CARTON | TABLET | 100 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-017-01 | EA - Each | 42292-017 | 8cd108e4-b464-4100-9b08-87c109e4ea12 | 1 | 2017-08-11 |
| 42292-017-20 | EA - Each | 42292-017 | 0113bb4e-b99c-4b82-b696-2531c5d9ad2c | 1 | 2017-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 57a2f9bd-8ca5-437e-b911-5207f94cc6ba | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | ab8115a0-e96f-7aee-e053-2995a90a6ec0 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f3191ca2-4dbc-01f5-e053-2a95a90a572c | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Menthozen | METHYL SALICYLATE, MENTHOL, CAPSAICIN | Village Pharma LLC | 48b1b99e-d0ec-4e5c-b80c-c0d2d87ecb13 | 2026-01-01 | Warnings | L7T10EIP3A |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | e3afa83d-c79c-848a-e053-2a95a90ac922 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f32b8809-80e9-18f2-e053-2995a90a5428 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 9ec3d35f-b25d-48f4-926f-f093e402ccde | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db118092-2002-7a55-e053-2a95a90a7b2c | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f331769a-ff11-6c68-e053-2a95a90a493b | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db4d84ce-cf51-61dc-e053-2a95a90a2cfd | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| spironolactone | SPIRONOLACTONE | Northwind Health Company, LLC | f988aa11-60ed-411e-e053-6294a90a522a | 2026-01-01 | Warnings, Adverse reactions | 27O7W4T232 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b94985-c79d-40e3-e053-2a95a90a0d78 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c97e38f2-7163-4d4e-a694-4d0612423e53 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2f3b60a-bffe-2675-e053-2995a90ae96e | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| spironolactone | SPIRONOLACTONE | Northwind Health Company, LLC | f32e8109-73e1-a249-e053-2995a90a3fae | 2026-01-01 | Warnings, Adverse reactions | 27O7W4T232 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f7091c54-0984-7f6e-e053-6394a90afb4d | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f68d211d-d802-6c78-e053-2995a90a90d7 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3984e6b9-2d88-47f0-af09-cce428bba14f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db895e64-3f97-9201-e053-2a95a90ac7ef | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| spironolactone | SPIRONOLACTONE | Northwind Health Company, LLC | f76b37a6-bcd4-2c8a-e053-6394a90aceea | 2026-01-01 | Warnings, Adverse reactions | 27O7W4T232 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.